Nasal spray that kills Covid virus in India soon
August 02, 2021  10:59
Right now, only vaccination helps reduce the risk of contraction
Right now, only vaccination helps reduce the risk of contraction
Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term strategic partnership to manufacture, market and distribute nitric oxide nasal spray (NONS) for Covid-19 treatment in India and other Asian markets.

The other Asian market include Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Sri Lanka, Timor-Leste and Vietnam. In March, SaNOtize's clinical trials showed NONS was a safe and effective anti-viral treatment to prevent the transmission of Covid-19, shorten its course and reduce the severity of symptoms.

In the first 24 hours, NONS reduced the average viral load by around 95 per cent and then by more than 99 per cent within 72 hours. It has been tested in healthy volunteers and patients as part of UK and Canada clinical trials.

Available in the form of a simple nasal spray, it is designed to kill the virus in the upper airways, preventing it from incubating and spreading to the lungs. It is based on nitric oxide (NO), a natural nano-molecule with proven anti-microbial properties, and which has a direct effect on SARS-CoV-2, the virus causing Covid-19.
« Back to LIVE

TOP STORIES